EAT is up +49.38%% since April’24 pick View All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CUBT
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Curative Biotechnology, Inc. stock price on Tuesday which ended trading at $0.0158
(Updated on Jun 25, 2024)

Hold candidate since Jun 25, 2024 PDF

The Curative Biotechnology, Inc. stock price gained 62.89% on the last trading day (Tuesday, 25th Jun 2024), rising from $0.0097 to $0.0158. During the last trading day the stock fluctuated 163.33% from a day low at $0.0060 to a day high of $0.0158. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 434 thousand more shares were traded than the day before. In total, 567 thousand shares were bought and sold for approximately $8.96 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -45.70% during the next 3 months and, with a 90% probability hold a price between $0.0051 and $0.0099 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CUBT Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, June 24, 2024, and so far it has risen 62.89%. Further rise is indicated until a new top pivot has been found. Curative Biotechnology, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Curative Biotechnology, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.0178. On a fall, the stock will find some support from the short-term average at $0.0151. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Curative Biotechnology, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0150 and $0.0148. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Curative Biotechnology, Inc. finds support just below today's level at $0.0150. If this is broken, then the next support from accumulated volume will be at $0.0148 and $0.0128.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0098 between high and low, or 163.33%. For the last week, the stock has had daily average volatility of 43.59%.

Our recommended stop-loss: $0.0151 (-4.12%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (CUBT) For The Upcoming Trading Day Of Wednesday 26th

For the upcoming trading day on Wednesday, 26th we expect Curative Biotechnology, Inc. to open at $0.0125, and during the day (based on 14 day Average True Range), to move between $0.0127 and $0.0189, which gives a possible trading interval of +/-$0.0031 (+/-19.70%) up or down from last closing price. If Curative Biotechnology, Inc. takes out the full calculated possible swing range there will be an estimated 39.39% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0163 (3.16%) than the support at $0.0150 (5.06%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Curative Biotechnology, Inc. stock A Buy?

Curative Biotechnology, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Hold/Accumulate candidate.

Current score: -0.819 Hold/Accumulate Upgraded

Predicted Opening Price for Curative Biotechnology, Inc. of Wednesday, June 26, 2024

Fair opening price June 26, 2024 Current price
$0.0125 ( 20.68%) $0.0158

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CUBT

Fibonacci Support & Resistance Levels

Level Price
R3 0.0223 41.35%
R2 0.0186 17.66%
R1 0.0163 3.02%
Price 0.0158
S1 0.0088 -44.37%
S2 0.0065 -59.01%
S3 0.0027 -82.70%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.0192 21.52%
R2 0.0190 20.25%
R1 0.0163 3.16%
Price 0.0158
S1 0.0150 -5.06%
S2 0.0148 -6.33%
S3 0.0128 -19.30%

FAQ

What is the symbol for Curative Biotechnology, Inc. Stock and on which exchange is it traded?
The symbol for Curative Biotechnology, Inc. is CUBT and it is traded on the PINK (Pink Sheets).

Should I buy or sell Curative Biotechnology, Inc. Stock?
Curative Biotechnology, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Hold/Accumulate candidate.

How to buy Curative Biotechnology, Inc. Stock?
Curative Biotechnology, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Curative Biotechnology, Inc. Stock.

What's the current price of Curative Biotechnology, Inc. Stock?
As of the end of day on the Jun 25, 2024, the price of an Curative Biotechnology, Inc. (CUBT) share was $0.0158.

What is the 52-week high and low for Curative Biotechnology, Inc. Stock?
The 52-week high for Curative Biotechnology, Inc. Stock is $0.0400 and the 52-week low is $0.0051.

What is the market capitalization of Curative Biotechnology, Inc. Stock?
As of the Jun 25, 2024, the market capitalization of Curative Biotechnology, Inc. is 9.937M.

When is the next earnings date for Curative Biotechnology, Inc.?
The upcoming earnings date for Curative Biotechnology, Inc. is Aug 05, 2024.
Click to get the best stock tips daily for free!

About Curative Biotechnology, Inc.

Curative Biotechnology. Curative Biotechnology, Inc. operates as a development-stage biomedical company. The company develops pipeline focusing on therapeutic areas, such as infectious diseases, oncology, and degenerative eye disease. Its pipeline candidates include IMT504, a novel immune therapy to treat rabies and an adjuvant for vaccines; CUBT906, a fully humanized CD56 monoclonal antibody carrying a pyrrolobenzodiazepine dimer directly to the tumor site to kill the ... CUBT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT